Career Development : Calendar

Suicide Prevention and Awareness


This video is now available on YouTube.

Science Talks is an educational webinar series for journalists presented by Wiley in partnership with the World Federation of Science Journalists (WFSJ) and the Association of Health Care Journalists (AHCJ). These complimentary, one-hour sessions are hosted by Wiley to provide journalists with on-going training in science topics of particular global importance.

The next webinar, Science Talks with The Association for Child and Adolescent Mental Health: Suicide Prevention and Awareness, will take place on Tuesday, Sept. 10, 2019, World Suicide Prevention Day, at 11 am ET.

Media interested in learning more about Suicide Prevention and Awareness to inform their reporting should attend. Participants will walk away with a deeper understanding of:

  • The prevalence and significance of suicidal and self-harm behaviour in young people.

  • Key risk factors for suicide and self-harm behaviour.

  • Diverse evidence-based and evidence-informed suicide preventive interventions.

  • How journalists can best report on suicide/self-harm to strengthen suicide prevention. 

The one-hour webinar will include time for questions and answers.


Science Talks webinars are complimentary to journalists:

Register for Science Talks here!

If you are not able to attend the live one-hour session the webinars will be recorded for later viewing on demand.

About the Speakers

Joan Asarnow is a Professor of Psychiatry and Biobehavioral Sciences at UCLA and Director of a SAMHSA-funded Center for Trauma-Informed Suicide, Self-Harm, and Substance Abuse Treatment and Prevention (ASAP Center). At UCLA, Dr. Asarnow directs the UCLA Youth Stress and Mood Program, a depression and suicide prevention program with clinical, educational, and research components. Dr. Asarnow has led efforts to develop and disseminate evidence-based treatments for youth suicide and suicide attempt prevention and depression. She received the 2017 Research Award from the American Foundation for Suicide Prevention for her work developing and evaluating treatment and service delivery strategies for youths suffering with suicidal and self-harm behaviors. Two programs developed by Dr. Asarnow were listed in the National Registry for Evidence-Based Programs (SAMHSA): 1) the Family Intervention for Suicide Prevention, a crisis treatment for youths after a suicidal/self-harm episode; and 2) Depression Treatment Quality Improvement, an evidence-based depression treatment program that has been integrated within primary care, mental health, and other settings. Dr. Asarnow has received grants from the National Institute of Mental Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Substance Abuse and Mental Health Services Administration (SAMHSA), American Foundation for Suicide Prevention, and other organizations. She currently serves on the Scientific Council of the American Foundation for Suicide Prevention and the Scientific Advisory Board of the Klingenstein Third Generation Foundation.

Dr. Dennis Ougrin, Consultant Child and Adolescent Psychiatrist, South London and Maudsley NHS Foundation Trust. Dr. Ougrin graduated from a medical school in Ukraine in 1998 and came to England to undertake his post-graduate training. He completed his higher training in child and adolescent psychiatry at Guy’s and Maudsley and is currently a consultant Child and Adolescent Psychiatrist leading Supported Discharge Service at South London and Maudsley NHS Foundation Trust. Dr. Ougrin is also a clinical senior lecturer at the Institute of Psychiatry, Psychology and Neuroscience. He leads a programme of information exchange between the UK and Ukraine. His main professional interests include prevention of Borderline Personality Disorder and effective interventions for self-harm. He is the author of Therapeutic Assessment, a novel model of assessment for young people with self-harm. He is the chief investigator of a randomised controlled trial of Supported Discharge Service versus Treatment as Usual in adolescents admitted for in-patient care and a principal investigator of a randomised controlled trial comparing intensive mental health intervention versus usual social care in Looked After Children. He also works on developing a modular psychotherapeutic intervention for self-harm and on understanding the pathophysiology of self-harm in young people.